In vitro anti-HIV activity of five selected South African medicinal plant extracts

Journal of Ethnopharmacology

Volumn 124, Issue 2, 2009, Pages 182-188

  Klos, M ^a   van de Venter, M ^a   Milne, P J ^a   Traore, H N ^b   Meyer, D ^c   Oosthuizen, V ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

^b UNIVERSITY OF JOHANNESBURG   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Bulbine alooides; Crinum macowani; HIV; Hypoxis sobolifera; Leonotis leonurus; Tulbaghia violacea

Indexed keywords

ALCOHOL; BULBINE ALOOIDES EXTRACT; CRINUM MACOWANI EXTRACT; HYPOXIS SOBOLIFERA EXTRACT; LEONOTIS LEONURUS EXTRACT; PLANT EXTRACT; PROTEINASE; RNA DIRECTED DNA POLYMERASE; TULBAGHIA VIOLACEA EXTRACT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BULBINE ALOOIDES; CONTROLLED STUDY; CRINUM MACOWANI; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIS SOBOLIFERA; IC 50; IN VITRO STUDY; LEONOTIS LEONURUS; MEDICINAL PLANT; SOLVENT EXTRACTION; SOUTH AFRICA; TULBAGHIA VIOLACEA; VIRUS REPLICATION;

ANGIOSPERMS; ANTI-RETROVIRAL AGENTS; ANTIVIRAL AGENTS; CELL LINE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PLANTS, MEDICINAL; POLYSACCHARIDES; TANNINS;

AMARYLLIDACEAE; ASPHODELACEAE; BULBINE; CRINUM; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOXIDACEAE; HYPOXIS; LAMIACEAE; LEONOTIS LEONURUS; LILIACEAE; TULBAGHIA VIOLACEA;

EID: 67549094640     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.04.043     Document Type: Article

References (30)

1. Asres K., Bucar F., Kartnig T., Witvrouw M., Pannecouque C., and De Clercq E. Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytotherapy Research 15 (2001) 62-69
2. Baba M., Snoeck R., Pauwels R., and De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 32 (1988) 1742-1745
3. Ballick M.J. Ethnobotany, drug development and biodiversity conservation-exploring the linkages. Ethnobotany and the Search for New Drugs, Ciba Foundation Symposium, vol. 185 (1994), John Wiley and Sons, Chichester 4-24
4. Cardellina II J.H., Murray H.G., Munro R.W., Fuller K.P., Manfredi T.C., McKee M.T., Bokesch H.R., Gustafson K.R., Beutler J.A., and Boyd M.R. A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory natural products. Journal of Natural Products 56 (1993) 1112-1129
5. Cardellina II J.H., and Boyd M.R. In: Hostettmann K. (Ed). Phytochemistry of Plants Used in Traditional Medicine (1995), Oxford University Press, New York 81-94
6. Chung K.T., Wei C.I., and Johnson M.G. Are tannins a double-edged sword in biology and health?. Trends in Food Science and Technology 9 (1998) 168-175
7. Collins R.A., Ng T.B., Fong W.P., Wan C.C., and Yeung H.W. Removal of polyphenolic compounds from aqueous plant extracts using polyamide minicolumns. Biochemistry and Molecular Biology International 45 (1998) 791-796
8. Cos P., Vanden Berghe D., Bruyne T.D., and Vlietinck A. Plant substances as antiviral agents: an update (1997-2001). Current Organic Chemistry 7 (2004) 1163-1180
9. Cowan M.M. Plant products as antimicrobial agents. Clinical Microbiology Reviews 12 (1999) 564-582
10. Devlin J.P., Carter C., and Homon C.A. In: Wagner H., and Farnsworth N.R. (Eds). Economic and Medicinal Plant Research vol. 5 (1991), Academic Press, London 1-20
11. Fabricant D.S., and Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives 109 (2001) 69-75
12. Farnsworth N.R. Ethnopharmacology and drug development. Ethnobotany, drug development and biodiversity conservation-exploring the linkages. Ethnobotany and the Search for New Drugs, Ciba Foundation Symposium, vol. 185 (1994), John Wiley and Sons, Chichester 42-59
13. Fletcher C.V., Kakuda T.N., and Collier A.C. In: Dipiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., and Posey L.M. (Eds). Pharmacotherapy-A Pathophysiologic Approach. 5th edition (2002), Mcgraw-Hill Medical Publishing Division, United States of America 2151-2174
14. Greene W.C., and Peterlin B.M. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nature Medicine 8 (2002) 673-680
15. Harnett S.M., Oosthuizen V., and van de Venter M. Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus. Journal of Ethnopharmacology 96 (2005) 113-119
16. Hauesser D.P., and Mulfinger L. HIV in Southern Africa: a need for the development of a vaccine with cross-clade activity. Journal of Young Investigators 4 (2001) 61-70
17. Hoggard P.G., and Owen A. The mechanisms that control intracellular penetration of the HIV protease inhibitors. Journal of Antimicrobial Chemotherapy 51 (2003) 493-496
18. Houghton P.J., and Raman A. Laboratory Handbook for the Fractionation of Natural Extracts (1998), Chapman and Hall, London/Weinheim/New York/Tokyo/Melbourne/Madras
19. Julkunen-Tiitto R. Phenolic constituents in the leaves of northern willows: methods for the analysis of certain phenolics. Journal of Agricultural and Food Chemistry 22 (1985) 213-217
20. Kubec R., Velisek J., and Musah R.A. The amino acid precursors and odor formation in society garlic (Tulbaghia violacea). Phytochemistry 60 (2002) 21-25
21. Lewis W.H., and Elvin-Lewis M.P.F. Medical Botany: Plants affecting Human Health. 2nd edition (2003), John Wiley and Sons, New Jersey pp. 97-129
22. Matayoshi E.D., Wang G.T., Krafft G.A., and Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science 247 (1990) 954-958
23. Motsei M.L., Lindsey K.L., van Staden J., and Jäger A.K. Screening of traditionally used South African Plants for antifungal activity against Candida albicans. Journal of Ethnopharmacology 86 (2003) 235-241
24. Scott G., Springfield E.P., and Coldrey N. A pharmacognostical study of 26 South African plant species used as traditional medicines. Pharmaceutical Biology 42 (2004) 186-213
25. Trkola A., Matthews J., Gordon C., Ketas T., and Moore J.P. A cell line-based neutralization assay for the primary human immunodeficiency virus type 1 isolates that use either CCR5 or CXCR4 coreceptor. Journal of Virology 73 (1999) 8966-8974
26. United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic (2006). http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp Available online: http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp
27. In: Van Wyk B., and Gericke N. (Eds). People's Plants: A Guide to Useful Plants of South Africa. first ed. (2000), Briza Publications, South Africa 10-12
28. Vermani K., and Garg S. Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology 80 (2002) 49-66
29. World Health Organisation (WHO). In vitro screening of traditional medicines for anti-HIV activity: memorandum from a WHO meeting. Bulletin of the World Health Organization 87 (1989) 613-618
30. World Health Organisation, Geneva (WHO). Report of a WHO Informal Consultation on Traditional Medicine and AIDS: In Vitro Screening for Anti-HIV Activity. Global Programme on AIDS and Traditional Medicine Programme (1989) pp. 1-17